Literature DB >> 11801906

Is coagulopathic liver disease a factor in spontaneous cerebral hemorrhage?

Huey-Jen Lee1, Clay R Hinrichs.   

Abstract

PURPOSE: Hepatic dysfunction is a common cause of thrombocytopenia and coagulopathy and has been reported as a causal factor in spontaneous intracranial hemorrhage. We attempt to define the prevalence of intracranial hemorrhage in patients with severe liver disease and coagulopathy.
METHOD: We retrospectively reviewed the medical records, CT, and MRI acquired between January 1996 and August 1999 of patients with liver disease and a coagulopathy admitted for nontraumatic acute mental status changes.
RESULTS: In 138 CT and MR scans performed on the 100 patients described above, no cases of spontaneous intracranial bleeding were detected.
CONCLUSION: Contrary to past reports, we find no instance of spontaneous intracranial hemorrhage in patients with coagulopathic liver disease presenting with acute mental status changes. Therefore, unless associated with trauma, spontaneous intracranial hemorrhage in coagulopathic liver disease is very uncommon.

Entities:  

Mesh:

Year:  2002        PMID: 11801906     DOI: 10.1097/00004728-200201000-00010

Source DB:  PubMed          Journal:  J Comput Assist Tomogr        ISSN: 0363-8715            Impact factor:   1.826


  3 in total

Review 1.  Differential diagnosis of nontraumatic intracerebral hemorrhage.

Authors:  Jennifer Linn; Hartmut Brückmann
Journal:  Klin Neuroradiol       Date:  2009-05-15

2.  Is cirrhosis associated with lower odds of ischemic stroke: A nationwide analysis?

Authors:  Abhinav Goyal; Kshitij Chatterjee; Nishi Shah; Shailender Singh
Journal:  World J Hepatol       Date:  2016-12-18

3.  Liver cirrhosis, other liver diseases, and risk of hospitalisation for intracerebral haemorrhage: a Danish population-based case-control study.

Authors:  Henning Grønbaek; Søren P Johnsen; Peter Jepsen; Mette Gislum; Hendrik Vilstrup; Ulrik Tage-Jensen; Henrik T Sørensen
Journal:  BMC Gastroenterol       Date:  2008-05-24       Impact factor: 3.067

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.